For our leadership and staff, this is personal. We have all had our own experiences with cancer. Many of us have lost family or friends. Many of us have felt the confusion, pain and sorrow that often accompany a cancer diagnosis. Every 1.7 seconds across the globe people are challenged with a new cancer diagnosis or a recurrence. These people are not alone in their fight against cancer, and we serve for their sake. Our leadership is the ideal blend of business savvy and medical expertise. Our founders have been working in healthcare for the last 35 years to optimize outcomes for people and their families, health insurers, and employers.
Jeff has been actively involved in cancer research, education, and healthcare IT for over 25 years. He has started and sold numerous companies including Educational Concepts in Medicine LLC, Broadleaf Creative Group LLC, and Strategic Edge Communications, Inc. As part of the Strategic Edge acquisition, he became the Chief Commercial Officer of MDOL, Inc. where he honed his skills in patient privacy and monetizing and leveraging “big data”. Jeff was instrumental in the November 2014 acquisition of MDOL, Inc. to the venture backed Ability Network, Inc. Jeff was recently honored by PM360, a well-respected health care publication with an entrepreneur award: https://www.pm360online.com/elite-entrepreneur-jeff-meehan-of-cancer-action-now/. Jeff sits on the board of Quality Cancer Care for All, a not for profit dedicated to bring quality cancer care to those that cannot afford it and he mentors young entrepreneurs.
Dr. Charles M. Balch has led a distinguished career as a clinical and academic surgical oncologist for the past 39 years, as a leading authority in both melanoma and breast cancer. He is author of over 730 publications and has lectured in over 38 different countries in the world and most of the major academic centers in the United States. Dr. Balch is the founding Editor-in-Chief of the Annals of Surgical Oncology, which is recognized as the leading journal in the world in its field.
In past years, Dr. Balch has served as Executive Vice President and CEO of the American Society of Clinical Oncology (2000-2005), and as President and CEO of the City of Hope National Medical Center (1996-1999). At the University of Texas M.D. Anderson Cancer Center, from 1985-1996, Dr. Balch served as Executive Vice President for Health Affairs, Vice President of Hospital and Clinics, and Head of the Division of Surgery, among other positions. Dr. Balch’s leadership roles have involved the Society of Surgical Oncology (as President in 1992), the American Board of Surgery (Board of Directors), the Association of Academic Surgeons (President) and the Commission on Cancer (Chair, Board of Directors) and the American Joint Committee on Cancer (Executive Committee).
Combining over 20 years of clinical practice experience and development of electronic health record software, Rich has been able to find the nexus between effective clinical workflows and healthcare information technology, resulting in greater adoption of EMR systems, maintaining productivity among clinicians as they migrate to new technologies, and improve the bottom line of physician practices. As an innovator in clinical record systems in an outpatient setting, he designed and developed EMR/EHR systems which improved clinician workflow, improved communications between clinicians and staff, and clinicians and their patients, simultaneously improving the practices’ bottom line by enabling workflow improvements across the practice enterprise.
Having navigated two EMR/EHR products to meaningful use certification (2011 edition and 2014 edition) he is uniquely aware of the impact of regulatory mandates in HIT on clinical practice, and can find ways to incorporate these requirements into clinically effective workflows which improve the user experience for physicians, staff, and patients. He is also expert in HIPAA privacy regulations, data integrity and security, and in optimizing the users technology experience.